|
|
||||||||||
|
J Am Coll Cardiol, 2005; 46:1565-1572, doi:10.1016/j.jacc.2005.06.065
(Published online 27 September 2005). © 2005 by the American College of Cardiology Foundation |

* Ospedale Bambino Gesù, Rome, Italy
Policlinico Universitario A. Gemelli Università La Cattolica, Rome, Italy
Manuscript received March 15, 2005; revised manuscript received May 30, 2005, accepted June 20, 2005.
* Reprint requests and correspondence: Dr. Maria Giulia Gagliardi, Dipartimento Medico-Chirurgico di Cardiologia Pediatrica, Ospedale Pediatrico Bambino Gesù, IRCCS, Piazza S. Onofrio, 4, 00165 Rome, Italy (Email: gagliard{at}opbg.net).
| Abstract |
|---|
|
|
|---|
BACKGROUND: Late coronary artery events occur in 3% to 8% of patients after the ASO. Previous studies of coronary flow reserve have yielded disparate results.
METHODS: Nineteen children previously underwent ASO (13 boys, age 5.4 ± 3.2 years, weight 22.3 ± 10.6 kg), and six control patients were enrolled in the study. Each patient underwent quantitative angiographic assessment of the epicardial coronary arteries before and after administration of nitroglycerin and coronary blood flow volume assessment before and after administration of adenosine and acetylcholine. The results were compared between groups.
RESULTS: Epicardial coronary artery dilation in response to intracoronary nitroglycerin was significantly less in the ASO group than in the control group (left anterior descending [LAD], 5.0 ± 0.05% vs. 18.0 ± 4.5%, p = 0.0009; right coronary artery [RCA], 4.0 ± 0.07% vs. 32.7 ± 12.7%, p = 0.006). Moreover, the coronary blood flow volume reserve was reduced in ASO patients compared with control patients after intracoronary infusion of acetylcholine (2.3 ± 0.9 vs. 4.9 ± 1.7, p = 0.0003) or adenosine (2.7 ± 1.5 vs. 5 ± 0.5, p = 0.002).
CONCLUSIONS: Epicardial coronary arteries fail to dilate normally in children after ASO, and the calculated coronary flow volume reserve is consequently reduced.
| |||||||||||||
Although the medium-term results of this operation are good (2), especially when compared with the atrial switch operation, its success is still affected by late coronary artery complications. Large studies (3,4) have shown a prevalence of coronary events, including sudden death and myocardial infarction, between 3% and 8% during follow-up periods up to 15 years. Children rarely report symptoms, and noninvasive methods have not been predictive of coronary abnormalities. The functional capacity of the coronary arteries after ASO remains unresolved. Some studies (58) performed with positron emission tomography (PET) have shown impaired global coronary flow volume reserve (CFR). More recently, Oskarsson et al. (9) have investigated coronary flow reserve using an intracoronary Doppler flow wire. Their data showed normal coronary flow velocity reserve (CVFR) in children after ASO. These apparently disparate results are likely related to the fact that those techniques measure different things. The PET uses an indicator dilution principle to measure volume flow. The coronary flow velocity measured by Doppler wire is related to volume flow by the cross-sectional area of the coronary artery. Normally, a decrease in coronary vascular resistance results in an increase in flow velocity in the epicardial vessel with a flow-induced increase in diameter (10). Consequently, a normal increase in flow volume depends not only on an increase in flow velocity in the epicardial vessels but also on dilation of the vessel. In the absence of normal dilation of the epicardial vessel, the increase in flow volume will be reduced despite a normal increase in flow velocity. Reduced or absent vasoreactivity of the epicardial vessel could explain the disparate results of the PET and Doppler wire studies.
The goal of this study was to assess the vasoreactivity of the translocated epicardial coronary arteries after ASO and to estimate CFR using quantitative angiographic analysis and intracoronary Doppler flow wire.
| Methods |
|---|
|
|
|---|
The anatomy of the coronary arteries was described according to the classification proposed by Yacoub (11). The right and left coronary ostia arose from the middle of the right and left septal sinuses (type A) in 14 patients, and in 3 patients the right coronary artery (RCA) gave origin to the circumflex coronary artery (type D). A single left coronary artery (LCA) (type B) was found in one case. The two coronary orifices originated close to each other near the facing commissure, with an intramural course of the RCA in the remaining case (type C) (Table 1).
|
The scientific and ethical committee of the Bambino Gesù Hospital approved the protocol, and the parents gave their consent.
Study protocol.
All patients were anesthetized, intubated, and mechanically ventilated during cardiac catheterization. Atropine was not administered at the time of pre-medication. Anesthesia was induced by inhalation of sevoflurane in 100% oxygen by mask and 2
/kg of remifentanil, 3
/kg of cisatracurium besylate, and 0.2 mg/kg of midazolam were administered intravenously. Anesthesia was maintained with 2
/kg/min of remifentanil, 0.1 mg/kg/h of cisatracurium besylate, and 0.1 mg/kg/h of midazolam. The FiO2 was 0.21 throughout the catheterization study. All patients received an intravenous bolus injection of heparin (100 IU/kg) after vascular access was obtained. Each patient underwent a routine cardiac catheterization including right and left ventriculography, pulmonary angiography, and aortography. Then selective coronary angiography was performed to evaluate possible macroscopic abnormalities of the coronary arteries and to serve as a baseline for quantitative angiographic assessment of the epicardial coronary arteries.
Quantitative coronary angiography.
We performed selective coronary angiography of both epicardial arteries (i.e., left and right) in all cases. Because of the anterior position of the translocated ostia, selective angiograms were performed exclusively with right coronary catheters. After the coronary artery ostium was cannulated, coronary angiography was performed by manual injection. High-resolution digital angiograms (resolution, 0.2 mm) were recorded of the RCA (right anterior oblique [RAO], 30°; left anterior oblique [LAO], 20°) and of the LCA (RAO, 20°; LAO, 90°) before and after an intracoronary bolus of nitroglycerin. To obtain maximal coronary dilation, we choose the dose of nitroglycerin based on data validated in adult patients. The recommended dose in the literature (12) is 200 µg for adults. Assuming an adult weight of 70 kg, we administered 3 µg/kg (
200 µg /70 kg). We used the LAO 20° for the RCA and the RAO 20° for the LCA to measure the diameter of the proximal, mid, and distal epicardial portions (13) of the left anterior descending artery (LAD) or RCA during diastole using commercially available quantitative digital system software (BICOR PLUS/TOP, Siemens, Munich, Germany). Two independent and blinded observers measured the vessel and calculated the change in diameter in response to nitroglycerin. Nitroglycerin infusion was performed in only one coronary artery in each child, the RCA in 10 ASO patients and 2 control patients, and the LCA in 9 ASO patients (including the child with a single LCA orifice) and 4 control patients.
Doppler flow wire technique. After coronary angiography, a 0.014-inch Doppler guide wire, with a 12-MHz piezoelectric transducer (FlowWire, Volcano Therapeutics Inc., Rancho Cordova, California) mounted on the tip was advanced into the proximal third of the LAD or of the RCA. The position of the wire was adjusted to obtain the highest-quality coronary Doppler flow signal. The ECG and arterial blood pressure, recorded invasively through a radial artery cannula, were continuously monitored and recorded on a magnetic tape recorder and played back for recording on paper at the end of each study.
Coronary blood flow velocity was measured by connecting the flow wire to a pulsed Doppler velocimeter. From the Doppler flow velocity spectra, the average peak velocity (APV) was calculated as the time-averaged value of the instantaneous peak velocity over two consecutive cardiac cycles. After obtaining a stable baseline flow velocity signal, acetylcholine (1.8 µg/min) and adenosine (270 µg/min) were alternately infused (1 ml/min) into the coronary artery ostium for a period of 3 min each. A washout period of at least five minutes was allowed between the two infusions. Acetylcholine and adenosine were infused at a concentration of 104 mol/l and 103 mol/l, respectively. Responses to adenosine and acetylcholine were expressed as the ratio of APV obtained after drug infusion to basal APV. The CVFR was calculated automatically by the Flow Map software based on the recordings of flow velocity at peak effect, after the administration of adenosine and acetylcholine. The CVFR was measured in the same coronary arteries in which the response to nitroglycerin was measured by quantitative angiography.
We estimated the volumetric coronary blood flow before and after administration of vasodilators according to the validated formula (14): cross-sectional area x APV x 0.5. For the cross-sectional area (CSA) of the epicardial vessel, we used the luminal diameter of the proximal epicardial vessel before and after nitroglycerin. Similarly, we used the APV at baseline and in response to vasoactive agents, adenosine, and acetylcholine. The CFR was calculated as the ratio of the coronary flow volume before and after hyperemic stimulus.
Data analysis. Continuous data are expressed as mean ± 1 standard deviation. Coronary blood flow velocity is expressed as average peak velocity throughout the cardiac cycle. The peak-to-baseline ratio of the diameter of the coronary artery before and after nitroglycerin and coronary blood flow velocity before and after adenosine and acetylcholine were calculated. The significance of differences in vessel diameter before and after administration of nitroglycerin and the significance of differences between flow velocity and volume before and after administration of acetylcholine and adenosine were evaluated using a Student t test for paired data for both control and ASO patients. The significance of intergroup comparisons was evaluated using a Student t test for unpaired data. A p value < 0.05 was considered statistically significant. Intraclass correlation coefficient was computed as a measure of interobserver reliability in the evaluation of results of quantitative coronary angiography.
| Results |
|---|
|
|
|---|
The study was terminated after the first 19 patients and 6 control patients because an interim analysis showed sufficient power to detect clinically meaningful differences between the study and control groups. This sample provided 80% power to detect a 10% difference in baseline coronary artery diameter between the study and control groups. We analyzed separately the coronary artery arising from the right sinus (RCA) and the one arising from the left sinus (LCA). The analysis of the RCA was conducted in 10 children and of the LCA in 9 children. The results are reported in Tables 2 and 3.
|
Nitroglycerin bolus in the study group. A reduction of arterial blood pressure between 10 and 25 mm Hg (10% to 15% from baseline) was observed after the intracoronary bolus of nitroglycerin, whereas the heart rate increased by <10% from baseline values. The diameter of neither the RCA nor the LAD increased significantly in response to nitroglycerin in the proximal, mid, or distal segments (p = not significant) (Table 3). The value of the intraclass correlation coefficient (average measure intraclass correlation coefficient, 0.98; 95% confidence interval, 0.95 to 0.99) indicated a high level of agreement between observers.
|
|
|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
On the other hand, coronary flow velocity increased to levels equivalent to those seen in control patients and normal values reported in both pediatric (15) and adults patients (16,17) in response to either an endothelium-dependent or endothelium-independent vasodilator. With failure of normal dilation of the epicardial vessel, a normal increase in flow velocity does not imply a normal increase in flow volume. In fact, estimates of the CFR were significantly reduced for children after ASO compared with the control group. Thus, normal coronary flow reserve requires normal dilatory function of the epicardial conduit arteries as well as normal capacity of the resistance vessels. Abnormalities of either component can result in impaired CFR.
A prior study using a Doppler flow wire also showed a normal increase in flow velocity in response to vasodilators (9). On the other hand (58), CFR after ASO measured using PET scanning has consistently been lower than normal. We believe that our findings explain this apparent discrepancy. Similar to a study of CFR using PET scanning (6), the baseline coronary flow volume in our ASO patients tended to be higher than in control patients, although this difference was not statistically significant. The coronary flow volume, diameter, and velocity did not seem to be related to coronary anatomy. We have no explanation for the trend toward increased baseline flow volume detected in our patients.
Differences in coronary flow reserve between coronary arteries. Previous studies (9,18) have shown differences in coronary flow velocities between the two main coronary arteries under certain circumstances. For example, the RCA flow velocity at rest has been shown to correlate with systolic right ventricular pressure in children and with the extent of right ventricular hypertrophy (9). Also, left ventricular hypertrophy and increased left ventricular diastolic pressure affects the coronary flow velocity and CFR (18). Previous reports in adults with normal coronary arteries (16) found no differences among the three main coronary arteries. Our sample included only patients without ventricular hypertrophy and with normal ventricular filling pressures.
Mechanisms. We did not investigate the mechanisms for abnormal epicardial coronary artery function in these patients. However, at least two possible causes are apparent. First, there is denervation of the coronary arteries because they are explanted from the aortic root and re-implanted into the pulmonary root and the aortic root is transacted (1). Second, dissection of the proximal coronary arteries to permit transfer from the aortic root to the pulmonary root might lead to disruption of the blood supply to the vessels with scarring and restriction of dilatory capacity.
Arterial wall fibrosis. During the ASO, the proximal coronary arteries are dissected free from the underlying tissue for some distance along the length of the artery to permit transfer to the opposite arterial root. This could disrupt the vascular supply to the vessel wall with subsequent scarring and fibrosis (19). Even without vascular disruption, simply dissecting the vessel from surrounding tissue is likely to cause scar formation around the vessel. Such changes could explain the abnormal vasomotor function observed in our patients. However, this does not explain the abnormal vasoreactivity seen in the more distal segments of the vessels. One cannot exclude possible indirect effects of proximal scar on the distal portions of the artery, leading to negative remodeling of the epicardial vessels, as recently reported by an intracoronary ultrasound study (20).
Role of shear stress. Normal elastic arteries are constantly subjected to both acute and chronic changes in blood flow. Variation in the forces acting on the endothelium is responsible, in part, for the regulation of vascular tone. Studies by several groups have identified abnormal shear stress as a stimulus for development and progression of atherosclerosis (2123). We suspect that the impaired vessel wall compliance and vasoreactivity, caused by denervation and/or direct vessel wall injury, alter intravascular hemodynamics producing abnormal patterns of flow and shear stress. Altered shear stress might lead to endothelial layer damage with precocious development of intimal thickening (24) and negative remodeling (20).
Study limitations. The small number of cases constituting our control group is a limitation of the study. However, the data are tightly clustered and in agreement with previous studies in children (15,25) and adults (9,12). It would be difficult to justify extending this group because the intracoronary Doppler study in these children presents some risks.
Although our data showed impairment of dilation of the epicardial coronaries in the ASO group, there was some heterogeneity in the response to nitroglycerin. A small subset of the ASO group showed an increase in diameter similar to the control group, whereas the rest had essentially no change in diameter. There were no obvious differences between these two subsets, but the number of patients is small. Moreover, we did not investigate the morphology of vessel wall and further studies are needed to show the structure of the vessel wall.
The calculation of CFR was based on the assumption that different vasodilators produce similar changes in diameter. We calculated the baseline and post-dilation cross-sectional area of the vessel using the proximal luminal diameter before and after nitroglycerin, but we used the APV measured before and after adenosine and acetylcholine. Nitroglycerin is a more potent vasodilator then either acetylcholine or adenosine, so the CFR may have been overestimated.
All examinations were performed during general anesthesia, so the baseline coronary flow velocity could have been lower than under physiological conditions, with a consequent overestimation of the CFR by Doppler technique.
In addition, several limitations of measurement of CFR by intracoronary Doppler wire should be pointed out (26). It is unclear how closely administration of vasodilator drugs mimics physiological stress. This technique measures total flow reserve for each coronary vessel and does not reflect regional heterogeneity of flow reserve or differences between the subendocardial and subepicardial layers.
| Conclusions |
|---|
|
|
|---|
This population of patients deserves close follow-up and more extensive investigation to understand the mechanisms involved in epicardial coronary artery dysfunction, the potential risks that it imposes, and methods for avoiding or treating this complication of the ASO.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
E. H. Aburawi, A. Berg, P. Liuba, and E. Pesonen Effects of cardiopulmonary bypass surgery on coronary flow in children assessed with transthoracic Doppler echocardiography Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1138 - H1143. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-E. W. Kavey, V. Allada, S. R. Daniels, L. L. Hayman, B. W. McCrindle, J. W. Newburger, R. S. Parekh, and J. Steinberger Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics Circulation, December 12, 2006; 114(24): 2710 - 2738. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. DeMaria, O. Ben-Yehuda, D. Berman, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, W. Y.W. Lew, D. Sahn, and S. Tsimikas Highlights of the Year in JACC 2005 J. Am. Coll. Cardiol., January 3, 2006; 47(1): 184 - 202. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |